Identifying the possible ubiquitination targets of RSPRY1 in this context and detailing the effects of these targets in the TGF-β signaling pathway may provide important information to elucidate the functional mechanism of RSPRY1 and develop therapeutic strategies for SEMD and other related pathologies. The gene discussed is RSPRY1; the disease is spondyloepimetaphyseal dysplasia.